Andrea Rachel LEUBITZ,Naamit SHER,Erez FEIGE,Eyal BREITBART
申请号：
US14767977
公开号：
US20160121001A1
申请日:
2014.02.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides methods of inducing or improving responsiveness to a VEGF antagonist to a subject or a subject population comprising administering an adenovirus comprising a nucleic acid construct comprising a FAS-chimera gene operably linked to an endothelial cell-specific promoter and administering the VEGF antagonist.
